All filters
Abstracts
Exploring the Role of Age in Transporter-Related Drug-Drug Interactions
H. Kinvig Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Genetic Associations With Weight Gain Among South Africans Who Initiated Dolutegravir- and Tenofovir-Containing Regimens in the ADVANCE Study
Z. Cindi Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Rifabutin Pharmacokinetics and Safety Among TB/HIV Coinfected Young Children Receiving Lopinavir
H. Rawizza Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Population Pharmacokinetic Modelling of Atazanavir in Plasma and Hair of HIV-Infected Women
L. Dickinson Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers: A Preliminary Analysis
J. George Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Does Dolutegravir Causes Weight Gain?: A Retrospective Observational Cohort Study From Lusaka, Zambia
D. Mwamba Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
The Pharmacokinetics (PK) of DOVATO (50 mg Dolutegravir (DTG)/ 300 mg Lamivudine (3TC)) Fixed-Dose Combination in HIV-Infected Patients
T. Pene Dumitrescu Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Evaluation of Relationships Between AB-506 Related ALT Elevations and AB-506 Pharmacokinetics (PK), Metabolite Concentrations and Plasma Bile Acids
H. Sevinsky Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Pharmacokinetics, Safety, and Tolerability of Dolutegravir + Rilpivirine (JULUCA) in Healthy Japanese Adults
R. Mehta Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Dolutegravir (DTG) Plasma Concentrations Under Different Combinations Regimens for ART- Pre-Treated Adults Living With HIV
A. Boussairi Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Tacrolimus and Sirolimus Doses in an HIV-Infected, Kidney-Recipient, Patient Requiring a Cobicistat-Based Antiretroviral Regimen
N. Diaz Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Systematic Review and Meta-Analysis of Adverse Perinatal Outcomes Associated With Prenatal Exposure to Protease Inhibitor Combination in Pregnant Women With HIV Infection
L. Saint-lary Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
In Utero Exposure to Antiretroviral Drugs and Pregnancy Outcomes: A Secondary Analysis of the ANRS Pharmacovigilance Database From the ANRS-Sponsored HIV Research Studies
L. Saint-Iary Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Impact of the Hepatitis B Virus (HBV) Capsid Inhibitor, AB-506, on the Single Dose Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)
H. Sevinsky Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Targeting Nuclear Receptors to Prevent Cobicistat Hepatotoxicity
A. Shehu Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
A Population Pharmacokinetic Analysis Assessing the Exposure of Raltegravir Once-Daily 1200mg in Pregnant Women Living With HIV
V. Bukkems Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Comparison of Relative Bioavailability of TIVICAY Neonatal Liquid Formulations to Pediatric Dispersible Tablets
R. Singh Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Impact of CYP2B6 Genotype, TB Therapy and Formulation on Efavirenz Pharmacokinetics in Infants and Children Under 40 Months of Age
M. Nikanjam Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Mechanistic Modelling for the Quantitative Evaluation of ARV Penetration in Lymphatic Tissues
F. Bunglawala Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
TFVdp/FTCtp Concentrations in Rectal Samples: No Correlation Between Epithelial Cells Collected by Cytobrush and Isolated CD4+ Cells
M Cottrell Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Intracellular EFdA Pharmacology Differs Between Species: Implications for Preclinical Study Design
M. Cottrell Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Inflammation Affects Antiretrovirals Plasma and Intracellular Exposure
M. Ferrara Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Lack of a Pharmacokinetic (PK) Interaction Between HIV-1 Maturation Inhibitor (MI) GSK3640254 (GSK’254) and Oral Contraceptive (OC) Ethinyl Estradiol (EE)/Levonorgestrel (LNG)
S. Joshi Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Lack of a Pharmacokinetic (PK) Interaction Between HIV-1 Maturation Inhibitor (MI) GSK3640254 and Dolutegravir
T. Pene Dumitrescu  Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020